Quantinno Capital Management LP Increases Position in Envista Holdings Corporation $NVST

Quantinno Capital Management LP increased its stake in shares of Envista Holdings Corporation (NYSE:NVST) by 38.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,694,970 shares of the company’s stock after purchasing an additional 753,474 shares during the quarter. Quantinno Capital Management LP’s holdings in Envista were worth $68,371,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in NVST. Royal Bank of Canada raised its holdings in Envista by 26.6% in the first quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock worth $401,000 after purchasing an additional 4,885 shares in the last quarter. Millennium Management LLC lifted its position in shares of Envista by 218.6% during the first quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after buying an additional 263,442 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after buying an additional 177,630 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Envista by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after buying an additional 76,246 shares in the last quarter. Finally, Prudential Financial Inc. boosted its holdings in shares of Envista by 22.1% in the 2nd quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after buying an additional 3,395 shares in the last quarter.

Envista Price Performance

Shares of NVST stock opened at $27.00 on Wednesday. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. The firm has a market capitalization of $4.39 billion, a price-to-earnings ratio of 65.85, a PEG ratio of 1.51 and a beta of 0.86. The stock’s 50-day simple moving average is $25.34 and its 200-day simple moving average is $25.82.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. The firm had revenue of $705.50 million during the quarter, compared to analyst estimates of $680.03 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. Envista’s revenue was up 14.4% on a year-over-year basis. During the same period last year, the firm posted $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities analysts forecast that Envista Holdings Corporation will post 1.42 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Zacks Research lowered shares of Envista from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. BMO Capital Markets initiated coverage on shares of Envista in a research note on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 target price for the company. Barclays cut their price target on shares of Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Wall Street Zen downgraded Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Finally, Morgan Stanley upped their price target on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, April 24th. Six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $28.54.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.